Venus Remedies Limited

Informe acción NSEI:VENUSREM

Capitalización de mercado: ₹4.3b

Salud financiera de hoja de balance de Venus Remedies

Salud financiera controles de criterios 6/6

Venus Remedies tiene un patrimonio de accionistas total de ₹4.7B y una deuda total de ₹417.4M, lo que sitúa su ratio deuda-patrimonio en 8.9%. Sus activos y pasivos totales son ₹6.4B y ₹1.7B respectivamente. El BAIT de Venus Remedies es de ₹365.1M, por lo que su ratio de cobertura de intereses es de -18.5. Tiene efectivo e inversiones a corto plazo que ascienden a ₹707.5M.

Información clave

8.5%

Ratio deuda-patrimonio

₹413.30m

Deuda

Ratio de cobertura de intereses370.7x
Efectivo₹871.90m
Patrimonio₹4.88b
Total pasivo₹1.39b
Activos totales₹6.27b

Actualizaciones recientes sobre salud financiera

Recent updates

Venus Remedies Limited (NSE:VENUSREM) Not Doing Enough For Some Investors As Its Shares Slump 26%

Mar 14
Venus Remedies Limited (NSE:VENUSREM) Not Doing Enough For Some Investors As Its Shares Slump 26%

Calculating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)

Oct 31
Calculating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)

Venus Remedies (NSE:VENUSREM) Seems To Use Debt Rather Sparingly

Jun 03
Venus Remedies (NSE:VENUSREM) Seems To Use Debt Rather Sparingly

Estimating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)

Jul 15
Estimating The Fair Value Of Venus Remedies Limited (NSE:VENUSREM)

Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?

May 31
Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?

I Ran A Stock Scan For Earnings Growth And Venus Remedies (NSE:VENUSREM) Passed With Ease

Mar 30
I Ran A Stock Scan For Earnings Growth And Venus Remedies (NSE:VENUSREM) Passed With Ease

Why Investors Shouldn't Be Surprised By Venus Remedies Limited's (NSE:VENUSREM) 25% Share Price Plunge

Feb 24
Why Investors Shouldn't Be Surprised By Venus Remedies Limited's (NSE:VENUSREM) 25% Share Price Plunge

Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?

Feb 01
Is Venus Remedies (NSE:VENUSREM) Using Too Much Debt?

Here's Why We Think Venus Remedies (NSE:VENUSREM) Is Well Worth Watching

Nov 16
Here's Why We Think Venus Remedies (NSE:VENUSREM) Is Well Worth Watching

Venus Remedies Limited's (NSE:VENUSREM) Stock Is Going Strong: Have Financials A Role To Play?

Mar 11
Venus Remedies Limited's (NSE:VENUSREM) Stock Is Going Strong: Have Financials A Role To Play?

We Think Venus Remedies (NSE:VENUSREM) Is Taking Some Risk With Its Debt

Jan 14
We Think Venus Remedies (NSE:VENUSREM) Is Taking Some Risk With Its Debt

Does Venus Remedies's (NSE:VENUSREM) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 23
Does Venus Remedies's (NSE:VENUSREM) Statutory Profit Adequately Reflect Its Underlying Profit?

Is Venus Remedies (NSE:VENUSREM) A Risky Investment?

Sep 22
Is Venus Remedies (NSE:VENUSREM) A Risky Investment?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₹3.7B) de VENUSREM superan a sus pasivos a corto plazo (₹1.1B).

Pasivo a largo plazo: Los activos a corto plazo de VENUSREM (₹3.7B) superan a sus pasivos a largo plazo (₹595.1M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: VENUSREM tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de VENUSREM ha pasado de 88.3% a 8.9% en los últimos 5 años.

Cobertura de la deuda: La deuda de VENUSREM está bien cubierta por el flujo de caja operativo (36%).

Cobertura de intereses: Los pagos de intereses de la deuda de VENUSREM están bien cubiertos por el BAIT (499.3x cobertura).


Hoja de balance


Descubre empresas con salud financiera